SATVI Director Professor Mark Hatherill has co-authored a commentary titled "WHO preferred product characteristics for new vaccines against tuberculosis" appearing in The Lancet journal.
Associate Professor Tom Scriba has co authored a paper titled "Can we predict tuberculosis cure? What tools are available?" appearing in the European Respiratory Journal of the European Respiratory Society.
Watch the press conference during which the primary results from the M72/AS01E candidate vaccine were announced during the Union World Conference on Lung Health. Professor Mark Hatherill, SATVI Director spoke on behalf of SATVI.
View the full list of SATVI speakers at the The Union World Conference on Lung Health held from 24 to 27 October 2018.